Suppr超能文献

2-(2-硝基-4-三氟甲基苯甲酰基)环己烷-1,3-二酮(NTBC)的组织分布:对大鼠酪氨酸分解代谢相关酶的影响及其与眼毒性的相关性

Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat.

作者信息

Lock E A, Gaskin P, Ellis M K, Provan W M, Robinson M, Smith L L, Prisbylla M P, Mutter L C

机构信息

Zeneca Central Toxicology Laboratory, Macclesfield, Cheshire, United Kingdom.

出版信息

Toxicol Appl Pharmacol. 1996 Dec;141(2):439-47. doi: 10.1006/taap.1996.0310.

Abstract

Administration of a single oral dose of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1,3-dione (NTBC) to rats produced a marked tyrosinemia in the plasma and aqueous humor. The tyrosinemia was both time- and dose-dependent with the duration being more marked at the higher doses. The dose-response curve was very steep with a single dose of 1.5 micromol NTBC/kg (0.5 mg/kg) and above producing maximal concentrations of tyrosine in plasma of about 2500 nmol/ml and in aqueous humor of about 3500-4000 nmol/ml at 24 hr after dosing. Analysis of the key hepatic enzymes involved in tyrosine catabolism showed that 4-hydroxyphenylpyruvate dioxygenase (HPPD) was markedly inhibited soon after dosing at either 0.3 or 30 micromol/kg (0.1 or 10 mg/kg) NTBC and that the activity recovered very slowly. In response to the tyrosinemia, the activity of tyrosine aminotransferase (TAT) in the liver was induced about twofold, while the activity of homogentisic acid oxidase (HGO) was not affected. Daily oral administration of NTBC for 6 weeks induced lesions to the cornea of the eye, with a dose of 0.3 micromol/kg/day producing about a 38% incidence and a higher dose of 30 micromol/kg/day a 75% incidence. Administration of a single oral dose of [14C]NTBC at either 0.3 or 30 micromol/kg led to selective retention of radiolabel in the liver and to a lesser extent in the kidneys and the Harderian gland. Concentrations of radioactivity in the liver and kidneys remained constant over 4 days and after the lower NTBC dose were about 2 nmol/g wet wt and 0.9 nmol/g wet wt, respectively. Subcellular fractionation of the liver showed that the majority of the radiolabel, >90%, was associated reversibly with the cytosol fraction. No retention of radiolabel was detected in the cornea, the site of toxicity. Our studies indicate that NTBC binds to protein in rat liver cytosol, inhibits the hepatic cytosolic enzyme HPPD, and causes a marked and sustained tyrosinemia. We suggest that this marked and sustained ocular tyrosinemia produced by NTBC in the rat is responsible for the corneal lesions since similar corneal lesions are produced by feeding rats a high tyrosine diet.

摘要

给大鼠单次口服一剂2-(2-硝基-4-三氟甲基苯甲酰基)环己烷-1,3-二酮(NTBC)后,血浆和房水中出现明显的酪氨酸血症。酪氨酸血症呈时间和剂量依赖性,在较高剂量时持续时间更明显。剂量反应曲线非常陡峭,单次剂量1.5微摩尔NTBC/千克(0.5毫克/千克)及以上,给药后24小时血浆中酪氨酸的最大浓度约为2500纳摩尔/毫升,房水中约为3500 - 4000纳摩尔/毫升。对参与酪氨酸分解代谢的关键肝酶分析表明,在给予0.3或30微摩尔/千克(0.1或10毫克/千克)NTBC后不久,4-羟基苯丙酮酸双加氧酶(HPPD)受到明显抑制,且活性恢复非常缓慢。作为对酪氨酸血症的反应,肝脏中酪氨酸转氨酶(TAT)的活性诱导增加约两倍,而尿黑酸氧化酶(HGO)的活性未受影响。每天口服NTBC 6周可导致眼部角膜病变,剂量为0.3微摩尔/千克/天的发病率约为38%,较高剂量30微摩尔/千克/天的发病率为75%。单次口服[14C]NTBC,剂量为0.3或30微摩尔/千克,导致放射性标记物在肝脏中选择性滞留,在肾脏和哈德氏腺中滞留程度较小。肝脏和肾脏中的放射性浓度在4天内保持恒定,较低剂量的NTBC给药后,肝脏和肾脏中的放射性浓度分别约为2纳摩尔/克湿重和0.9纳摩尔/克湿重。肝脏的亚细胞分级分离显示,大部分放射性标记物(>90%)与胞质溶胶部分可逆结合。在毒性部位角膜中未检测到放射性标记物的滞留。我们的研究表明,NTBC与大鼠肝脏胞质溶胶中的蛋白质结合,抑制肝脏胞质酶HPPD,并导致明显且持续的酪氨酸血症。我们认为,NTBC在大鼠中产生的这种明显且持续的眼部酪氨酸血症是角膜病变的原因,因为给大鼠喂食高酪氨酸饮食也会产生类似的角膜病变。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验